Keystone Heart
Signal active
Organization
Contact Information
Overview
Keystone Heart aspires to be the world leader in embolic cerebral protection for cardiovascular procedures.
To develop and manufacture cerebral protection devices, focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, AF ablation and other structural heart procedures.
Cerebral function is the essence of quality of life. Preserving brain reserve throughout medical procedures is a key component to procedural success and patient care.
About
Industries
Health Care, Medical, Manufacturing, Health Diagnostics
Founded
2004
Employees
11-50
Headquarters locations
Herzliya, Tel Aviv, Israel, Asia
Social
Profile Resume
Keystone Heart headquartered in Asia, operates in the Health Care, Medical, Manufacturing, Health Diagnostics sector. The company focuses on Health Care and has secured $224.0M in funding across 16 round(s). With a team of 11-50 employees, Keystone Heart is actively contributing to advancements in Health Care. Their latest funding round, Series B - Keystone Heart, raised $14.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
2
Lead Investors
0
Total Funding Amount
$14.0M
Details
1
Keystone Heart has raised a total of $14.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2014 | Early Stage Venture | 14.0M |
Investors
Keystone Heart is funded by 4 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Keystone Heart | - | FUNDING ROUND - Keystone Heart | 14.0M |
| Caesarea Medical Electronics | - | FUNDING ROUND - Caesarea Medical Electronics | 14.0M |
| Keystone Heart | - | FUNDING ROUND - Keystone Heart | 14.0M |
| OrbiMed | - | FUNDING ROUND - OrbiMed | 14.0M |